Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Histamine
100%
Cutaneous Blood Flow
94%
Forearm
90%
Skin Blood Flow
88%
Methyl Nicotinate
84%
Pemphigus
81%
Laser Doppler Velocimetry
77%
Regional Variation
75%
Human Skin
69%
Laser Doppler Flowmetry
67%
Kaposi Sarcoma
58%
Exogenous Factors
56%
Flow Response
52%
Blood Flow
45%
Perfusion
44%
Blood Vessels
39%
Percutaneous Absorption
39%
Interferon-α (IFN-α)
38%
Pemphigus Vulgaris
37%
Photoplethysmography
37%
Plethysmography
36%
Ulcer
35%
Vasodilatation
35%
Non-invasive Assessment
33%
Age-related
33%
Pharmacodynamics
33%
Skin pH
33%
Vitiligo
33%
Healthy Controls
32%
Reactive Hyperemia
31%
Malignancy
31%
Cutaneous Manifestations
30%
Skin Function
30%
Peak Response
30%
Topical Application
30%
No Significant Difference
27%
Cutaneous Microcirculation
27%
Non-insulin-dependent Diabetes Mellitus (NIDDM)
26%
Skin Moisture
25%
Response Time
24%
Control Subjects
23%
Diabetic Patients
23%
Racial Differences
22%
Moisture
22%
Acantholysis
22%
Methyl
22%
Skin Site
22%
Percutaneous Penetration
22%
Tannins
20%
Blood Flow Measurement
20%
Medicine and Dentistry
Skin Blood Flow
70%
Laser Doppler Flowmetry
64%
Diseases
42%
Diabetes Mellitus
41%
Kaposi Sarcoma
41%
Ulcer
35%
Pemphigus
33%
Histamine
33%
Vitiligo
33%
Nicotinic Acid Methyl Ester
33%
Cancer
30%
Maturity Onset Diabetes of the Young
30%
Vascular Bundle
25%
Blood Flow
23%
Plethysmography
22%
Microcirculation
22%
Hyperaemia
20%
Dermatology
20%
Skin Absorption
20%
Melanoma
16%
Gestational Hypertension
16%
Blood Flowmetry
16%
Environmental Factor
16%
Hyperpigmentation
16%
Low Drug Dose
16%
Scrofuloderma
16%
Erythema Induratum
16%
Topical Corticosteroid
16%
Scabies
16%
Leukocyte
16%
Spitz Nevus
16%
Minocycline
16%
Sunburn
16%
Skin Defect
16%
Pemphigus vulgaris
16%
Mycosis fungoides
16%
Food Frequency Questionnaire
16%
Interferon Alfa
16%
Vacuolization
16%
Corticosteroid Therapy
16%
Duodenum Ulcer
16%
Nifedipine
16%
Intertrigo
16%
Pemphigoid
16%
In Vitro
16%
Hydrogen Peroxide
16%
Skin Surface
16%
Substance P
16%
Non Invasive Procedure
13%
Topical Drug Administration
13%
